Siegfried Holding AGXSWX:SFZN -1.59%90 3-Year ROIIC % is 2.96 as of Dec. 2025, which is 82% below its 10-year median of 16.39. GuruFocus rates XSWX:SFZN with a GF Score™ of 90/100 and a GF Value™ of CHF92.27 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 944 Drug Manufacturers companies, Siegfried Holding AG ranks worse than 51.59% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Siegfried Holding AG's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 2.96%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Siegfried Holding AG's 3-Year ROIIC % or its related term are showing as below:
XSWX:SFZN's 3-Year ROIIC % is ranked worse than 51.59% of 944
companies
in the Drug Manufacturers industry
Industry Median: 3.635
vs XSWX:SFZN: 2.96
Siegfried Holding AG (XSWX:SFZN) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Siegfried Holding AG 3-Year ROIIC % Related Terms
Siegfried Holding AG 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Siegfried Holding AG's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SFZN vs ZTS, UTHR, VTRS: 3-Year ROIIC % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siegfried Holding AG 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Siegfried Holding AG's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Siegfried Holding AG (XSWX:SFZN) has a 3-Year ROIIC % of 2.96 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Siegfried Holding AG and its competitors. This is 82% below median its historical median of 16.39. Over the past decade, Siegfried Holding AG's 3-Year ROIIC % has ranged from 2.35 to 24.41. According to the industry distribution chart, Siegfried Holding AG ranks #487 out of 944 companies in the Drug Manufacturers industry, placing it in the top 51.6%.
Is Siegfried Holding AG's 3-Year ROIIC % too high?
Siegfried Holding AG's current 3-Year ROIIC % of 2.96 is 82% below median its 10-year median of 16.39. Over the past 10 years, this metric has ranged from a low of 2.35 to a high of 24.41. The Drug Manufacturers industry median 3-Year ROIIC % is 3.64. Siegfried Holding AG's value of 2.96 is 18.6% below this industry median. Based on the distribution chart, Siegfried Holding AG ranks #487 out of 944 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Siegfried Holding AG has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's 3-Year ROIIC % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #487 out of 944 companies for 3-Year ROIIC %. This places Siegfried Holding AG in the lower half of its industry. The industry median 3-Year ROIIC % is 3.64. Siegfried Holding AG's value of 2.96 is 18.6% below this benchmark. Historically, Siegfried Holding AG's own 3-Year ROIIC % has ranged from 2.35 to 24.41 over the past decade. While the company's 10-year median is 16.39 vs. the industry median of 3.64, Siegfried Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.64, based on 944 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siegfried Holding AG's current 3-Year ROIIC % of 2.96 is 18.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Siegfried Holding AG and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current 3-Year ROIIC % is 2.96, which is 82% below median its own 10-year median of 16.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF92.27, compared to a current price of CHF71.05 — trading 23% below its estimated fair value. The current 3-Year ROIIC % is 2.96, which is 82% below median its 10-year median of 16.39 and 18.6% below the Drug Manufacturers industry median of 3.64. Siegfried Holding AG's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current 3-Year ROIIC % is 2.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?
Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued.
The current stock price of CHF71.05 is trading 23% below its estimated GF Value™ of CHF92.27.
GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SFZN:
3-Year ROIIC %: 2.96 (82% below median its 10-year median of 16.39)
GF Value™: CHF92.27 vs. price of CHF71.05 (23% below fair value)
Industry Position: 18.6% below the Drug Manufacturers median (#487 of 944)
No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
90GF Score
Get the complete analysis for XSWX:SFZN
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SFZN has been successfully added to your 
